Category:

Pandemic

Latest

Downbeat Indian consumers withhold spending amid pandemic, says RBI survey

“The sentiments on overall spending remained unchanged as higher spending on essential items were offset by a drop in non-essential expenditure with consumers expecting further contraction in discretionary expenditure in the year ahead,” the RBI said.

With forecasters warning of a third wave, any new restrictions could spell more bad news for the country, where private consumption makes up some 60% of gross domestic product.

J&J seeks emergency use nod for COVID-19 vaccine in India

Indian health authorities have so far approved the use of vaccines developed by AstraZeneca,  Bharat Biotech, Russia’s Gamaleya Institute and Moderna.

The government and Moderna are still trying to sort out issues over imports of the vaccine and indemnity, a top executive at Indian drugmaker and Moderna’s local distribution partner Cipla told Reuters in an interview on Friday.

India’s peak holiday season set to send COVID-19 cases surging

“We will probably have more deaths out of starvation if the rural migratory population who flock to cities during the pujas and earn some money during the festivity are deprived of the opportunity,” said Subrata Mukherjee, a cabinet minister in the fourth-most populous state of West Bengal, which has one of India’s highest coronavirus caseloads.

read more

Oxford scientists develop five-minute COVID-19 antigen test

“Our method quickly detects intact virus particles,” said Professor Achilles Kapanidis, at Oxford’s Department of Physics, adding that this meant the test would be “simple, extremely rapid, and cost-effective”.

Rapid antigen tests are seen as key in rolling out mass-testing and re-opening economies while the coronavirus is still circulating, and those that are already in use are faster and cheaper but less accurate than existing molecular PCR tests.

read more

Risk Management: COVID-19 spurs collaboration and innovation

Risk management and transfer has always been about collaboration between client, broker and insurance carrier to find the most suitable solutions for risk problems. Without a doubt, the COVID-19 pandemic has forced us all to find different ways to do that – with the opportunity for face-to-face brainstorming put on hold, we need to find other ways to continue to innovate.

read more

WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients

“The emerging (WHO) data appears inconsistent, with more robust evidence from multiple randomized, controlled studies published in peer-reviewed journals validating the clinical benefit of remdesivir,” Gilead told Reuters.

“We are concerned the data from this open-label global trial has not undergone the rigorous review required to allow for constructive scientific discussion, particularly given the limitations of the trial design.”

read more

World Bank approves $12B to finance Virus Vaccines, Care

The world’s richest countries have locked up most of the world’s potential vaccine supply through 2021, raising worries that poor and vulnerable communities will not be able to get the shots. Meanwhile, an ambitious international project to deliver coronavirus vaccines to the world’s poorest people, called Covax, is facing potential shortages of money, cargo planes, refrigeration and vaccines themselves.

read more